NEW YORK, Aug. 25 /PRNewswire/ — Reportlinker.com announces
that a new market research report is available in its
catalogue:
Pharmaceutical M&A in the Asia-Pacific Region – India and
China drive regional activity but Japan still dominates high value
transactions
http://www.reportlinker.com/p0284560/Pharmaceutical-MA-in-the-Asia-Pacific-Region-––India-and-China-drive-regional-activity-but-Japan-still-dominates-high-value-transactions.html
IntroductionExpanding healthcare coverage in emerging
Asia-Pacific markets, rapid economic growth and burgeoning middle
classes are attracting foreign M&A as companies attempt to
offset future losses from the looming threat of the 2011 “patent
cliff” and slowing growth in major developed markets. As these
markets develop, consolidation of the domestic industry is also
driving M&A in the Asia-Pacific region.
Scope*Provides an overview of the healthcare systems and
pharmaceutical markets of key countries within
Asia-Pacific.
*Overview of drivers, resistors and trends within the
Asia-Pacific M&A landscape.
*Analysis of the types of acquisitions and healthcare sectors
targeted.
*Analysis of geographic M&A activity and transaction
values.
HighlightsSluggish performance in the major pharmaceutical
markets prompted by growing generic competition and increasing
healthcare cost-containment are forcing companies to seek
opportunities elsewhere. Massive populations, rapid economic growth
and burgeoning middle classes make emerging Asia-Pacific markets
particularly attractive t
‘/>”/>
SOURCE
